The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma

Accuracy of a Novel Handheld Wireless Platform for Detection of Cardiac Dysfunction in Anthracycline-Exposed Survivors of Childhood Cancer

(2018) Saro H. Armenian et al.   CLINICAL CANCER RESEARCH

Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer

(2018) Fan Mo et al.   EUROPEAN UROLOGY

Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers

(2018) Alhadi Almangush et al.   HISTOPATHOLOGY

Targeting the tumour stroma to improve cancer therapy

(2018) Kenneth C. Valkenburg et al.   Nature Reviews Clinical Oncology

Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor

(2018) Ming-Xiang Zou et al.   NEUROSURGERY

Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis

(2018) Ming-Xiang Zou et al.   World Neurosurgery

Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival

(2017) Bernhard Mlecnik et al.   JNCI-Journal of the National Cancer Institute

The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease

(2017) Gero Brockhoff et al.   Oncotarget

Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival

(2017) Bernhard Mlecnik et al.   JNCI-Journal of the National Cancer Institute

First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies

(2017) Denis Migliorini et al.   OncoImmunology

Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer

(2016) Xiaoxian Li et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma

(2016) H. Miyoshi et al.   BLOOD

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

(2016) Kurt A. Schalper et al.   CLINICAL CANCER RESEARCH

Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute

(2016) Yongkun Yang et al.   EUROPEAN SPINE JOURNAL

Prognostic Biomarkers in Spinal Chordoma: A Systematic Review

(2016) Ming-Xiang Zou et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Stromal contributions to the carcinogenic process

(2016) Mark Spaw et al.   MOLECULAR CARCINOGENESIS

Management of Locally Recurrent Chordoma of the Mobile Spine and Sacrum

(2016) Tamir Ailon et al.   SPINE

Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis

(2016) Jiayuan Wu et al.   Oncotarget

Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology–Genomic Integration Analysis

(2016) Rachael Natrajan et al.   PLOS MEDICINE

Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator

(2016) Y. Kurebayashi et al.   Cancer Immunology Research

S100A8+ stroma cells predict a good prognosis and inhibit aggressiveness in colorectal carcinoma

(2016) Si Li et al.   OncoImmunology

Prognostic factors in surgical resection of sacral chordoma

(2015) Andrea Angelini et al.   JOURNAL OF SURGICAL ONCOLOGY

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non–Small Cell Lung Cancer

(2015) Andrew J. Gentles et al.   JNCI-Journal of the National Cancer Institute

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

(2015) Alexandre Calon et al.   NATURE GENETICS

Differential proteomic profiling of primary and recurrent chordomas

(2015) SU CHEN et al.   ONCOLOGY REPORTS

Tumor–stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation

(2015) Zhen Lv et al.   SURGERY

Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus

(2015) Ahmed Q. Haddad et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma

(2015) Yong Feng et al.   Oncotarget

Quantitative histology analysis of the ovarian tumour microenvironment

(2015) Chunyan Lan et al.   Scientific Reports

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non–Small Cell Lung Cancer

(2015) Andrew J. Gentles et al.   JNCI-Journal of the National Cancer Institute

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer

(2014) C L Downey et al.   BRITISH JOURNAL OF CANCER

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer

(2014) F J A Gujam et al.   BRITISH JOURNAL OF CANCER

Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer

(2014) M.-G. Anitei et al.   CLINICAL CANCER RESEARCH

A review of the surgical management of sacral chordoma

(2014) B. Kayani et al.   EJSO

Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center

(2014) T. Meng et al.   NEURO-ONCOLOGY

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer

(2013) S. Muenst et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of Clinical and Histopathological Parameters on Disease Specific Survival in Patients with Collecting Duct Renal Cell Carcinoma: Development of a Disease Specific Risk Model

(2013) Matthias May et al.   JOURNAL OF UROLOGY

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

(2013) L.-C. S. Wang et al.   Cancer Immunology Research

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

(2012) A. Huijbers et al.   ANNALS OF ONCOLOGY

Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment

(2012) C. Desmedt et al.   CLINICAL CANCER RESEARCH

The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature

(2012) R. J. deLeeuw et al.   CLINICAL CANCER RESEARCH

The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?

(2012) Susanne Sebens et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Cancer classification using the Immunoscore: a worldwide task force

(2012) Jérôme Galon et al.   Journal of Translational Medicine

Chordoma: current concepts, management, and future directions

(2012) Brian P Walcott et al.   LANCET ONCOLOGY

Tumor stroma as targets for cancer therapy

(2012) Jing Zhang et al.   PHARMACOLOGY & THERAPEUTICS

Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomas

(2012) XIAOXIANG LI et al.   Oncology Letters

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

(2011) M J M Gooden et al.   BRITISH JOURNAL OF CANCER

Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells – Associations with histopathology and patients outcome

(2010) Søren Astrup Jensen et al.   EUROPEAN JOURNAL OF CANCER

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein- 

(2010) M. Kraman et al.   SCIENCE

Surgical Management of Primary Bone Tumors of the Spine

(2010) Charles G. Fisher et al.   SPINE

Brachyury Expression in Extra-axial Skeletal and Soft Tissue Chordomas: A Marker that Distinguishes Chordoma From Mixed Tumor/Myoepithelioma/Parachordoma in Soft Tissue

(2009) Roberto Tirabosco et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers

(2009) Silvia Stacchiotti et al.   ANNALS OF SURGICAL ONCOLOGY

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE

Co-evolution of tumor cells and their microenvironment

(2008) Kornelia Polyak et al.   TRENDS IN GENETICS